This section shows a general overview of information for the selected study (COSU identifier) or publication (COSP identifier). Studies may have been performed by the Sanger Institute Cancer Genome Project, or imported from the ICGC/TCGA. You can see more information on the help pages.
- Targeted sequencing and molecular profiling of a papillary and cribriform clear cell intrahepatic cholangiocarcinoma reveals absence of selectable mutations.
- Paper ID
- Department of Pathology, Biomedical Diagnostic Center-CDB, Hospital Clinic - University of Barcelona, Barcelona, Spain. Electronic address: email@example.com.
Gastroenterologia y hepatologia, 2018
PMID: 30293915 (view at PubMed or Europe PMC)
- Paper Status
- Genes Analysed
- Mutated Samples
- Total No. of Samples